[144] Sight Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) Form 144 summary: The filing notifies a proposed sale of 19,948 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $65,750.60. The sale is scheduled for 10/02/2025 on NASDAQ and the issuer reports 52,367,359 shares outstanding. The shares were acquired on 09/30/2025 through restricted stock vesting and were recorded as compensation. The filer also disclosed a prior sale of 19,260 shares on 07/02/2025 that generated $78,933.26 in gross proceeds. The notice includes the standard signature representation that the seller is unaware of undisclosed material adverse information.

Positive

• Acquisition via restricted stock vesting on 09/30/2025 (19,948 shares)
• Full disclosure of broker and planned sale date for compliance (Fidelity; 10/02/2025)

Negative

• Insider proposes to sell 19,948 shares (aggregate market value $65,750.60) on 10/02/2025
• Prior insider sale of 19,260 shares on 07/02/2025 (gross proceeds $78,933.26)

Insights

Insider Transactions Analyst

TL;DR: Insider plans to sell ~19.9k shares after restricted stock vesting; another ~19.3k shares were sold in July.

The filing shows a proposed open-market sale of 19,948 common shares scheduled for 10/02/2025, following a restricted stock vesting on 09/30/2025 that delivered those shares as compensation. The filer previously sold 19,260 shares on 07/02/2025 for $78,933.26. These are explicit, recorded insider transactions rather than purchases or transfers.

Why it matters: Insider sales change immediate share supply and are routinely monitored by investors for timing and size; both the proposed sale and the prior sale are documented with dates and amounts in the filing.

Securities Compliance Counsel

TL;DR: Form 144 documents compliance with Rule 144 for a compensatory restricted stock sale and includes the seller's attestation.

The submission identifies the acquisition as restricted stock vesting and lists the sale broker and planned sale date, fulfilling the Form 144 disclosure elements. The notice includes the seller's signed representation that no undisclosed material adverse information is known, and warns of criminal penalties for misstatements.

This filing is a procedural disclosure required before an intended resale under Rule 144 and records the factual elements needed for compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	19948	65750.60	52367359	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Restricted Stock Vesting	Issuer			19948	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alison Bauerlein 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	07/02/2025	19260	78933.26

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the SGHT Form 144 report a proposed sale for?

The filing reports a proposed sale of 19,948 common shares on NASDAQ.

When is the planned sale date and which broker is named?

The sale is scheduled for 10/02/2025 and lists Fidelity Brokerage Services LLC as the broker.

How were the shares being sold acquired?

The shares were acquired on 09/30/2025 through restricted stock vesting and recorded as compensation.

How many shares outstanding does the filing list for the issuer?

The filing lists 52,367,359 shares outstanding.

Has the filer sold shares of the issuer recently?

Yes. The filing discloses a prior sale of 19,260 shares on 07/02/2025 for $78,933.26 in gross proceeds.